Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles
Gerald M. Reaven, … , Pierre Maheux, Ronald M. Krauss
Gerald M. Reaven, … , Pierre Maheux, Ronald M. Krauss
Published July 1, 1993
Citation Information: J Clin Invest. 1993;92(1):141-146. https://doi.org/10.1172/JCI116541.
View: Text | PDF
Research Article Article has an altmetric score of 29

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

  • Text
  • PDF
Abstract

Authors

Gerald M. Reaven, Y.-D. Ida Chen, Jorgen Jeppesen, Pierre Maheux, Ronald M. Krauss

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1957 Total
Citations: 1 2 2 4 9 2 5 6 6 7 9 12 13 9 16 11 16 17 26 23 20 21 27 37 19 23 31 23 33 23 24 12 1 1 491
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (491)

Title and authors Publication Year
Triglyceride/high density lipoprotein cholesterol index and future cardiovascular events in diabetic patients without known cardiovascular disease
Nakashima R, Ikeda S, Shinohara K, Matsumoto S, Yoshida D, Ono Y, Nakashima H, Miyamoto R, Matsushima S, Kishimoto J, Itoh H, Komuro I, Tsutsui H, Abe K
Scientific Reports 2025
Use of Lipid Ratios to Predict Vascular Target Organ Damage in Youth
Henson SE, Urbina EM
Journal of Clinical Lipidology 2024
Chronically Increased Levels of Circulating Insulin Secondary to Insulin Resistance: A Silent Killer.
Fazio S, Bellavite P, Affuso F
Biomedicines 2024
Knockout of murine Lyplal1 confers sex-specific protection against diet-induced obesity.
Vohnoutka RB, Kuppa A, Hegde Y, Chen Y, Pant A, Tohme ME, Choi EK, McCarty SM, Bagchi DP, Du X, Chen Y, Chen VL, Mori H, Bielak LF, Maguire LH, Handelman SK, Sexton JZ, Saunders TL, Halligan BD, Speliotes EK
Journal of molecular endocrinology 2023
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H
Journal of Atherosclerosis and Thrombosis 2023
Atherogenic index of plasma is associated with epicardial adipose tissue volume assessed on coronary computed tomography angiography.
Yuvaraj J, Isa M, Che ZC, Lim E, Nerlekar N, Nicholls SJ, Seneviratne S, Lin A, Dey D, Wong DTL
Scientific Reports 2022
A Clinical Case of a Homozygous Deletion in the APOA5 Gene with Severe Hypertriglyceridemia.
Vasiluev PA, Ivanova ON, Semenova NA, Strokova TV, Taran NN, Chubykina UV, Ezhov MV, Zakharova EY, Dadli EL, Kutsev SI
Genes & development 2022
Protective effect of microorganism biotransformation-produced resveratrol on the high fat diet-induced hyperlipidemia, hepatic steatosis and synaptic impairment in hamsters.
Su CH, Wang HL, Tsai ML, Lin YC, Liao JM, Yen CC, Ting HC, Yu CH
International journal of medical sciences 2022
The relationship between insulin resistance and ion mobility lipoprotein fractions.
Rowland CM, Abbasi F, Shiffman D, Knowles JW, McPhaul MJ
2022
Nutrient infusion in the dorsal vagal complex controls hepatic lipid and glucose metabolism in rats
RJ Li, B Batchuluun, SY Zhang, MA Abraham, B Wang, YM Lim, JT Yue, TK Lam
iScience 2021
Association between insulin resistance and left ventricular hypertrophy in asymptomatic, Black, sub-Saharan African, hypertensive patients: a case–control study
BK Phanzu, AN Natuhoyila, EK Vita, JR Kabangu, B Longo-Mbenza
BMC Cardiovascular Disorders 2021
Hiding unhealthy heart outcomes in a low-fat diet trial: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial finds that postmenopausal women with established coronary heart disease were at increased risk of an adverse outcome if they consumed a low-fat ‘heart-healthy’ diet
TD Noakes
Open Heart 2021
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association
D Kalra, K Vijayaraghavan, G Sikand, NR Desai, PH Joshi, A Mehta, W Karmally, A Vani, SJ Sitafalwalla, R Puri, PB Duell, A Brown
Journal of Clinical Lipidology 2021
The effect of vitamin C supplementation on lipid profile of type 2 diabetic patients: a systematic review and meta-analysis of clinical trials
AA Tareke, AA Hadgu
Diabetology & metabolic syndrome 2021
Mechanisms and Treatment of Dyslipidemia in Diabetes
E Bahiru, R Hsiao, D Phillipson, KE Watson
Current Cardiology Reports 2021
Insulin resistance-related differences in the relationship between left ventricular hypertrophy and cardiorespiratory fitness in hypertensive Black sub-Saharan Africans
Bernard Kianu Phanzu, Aliocha Nkodila Natuhoyila, Annie Nzundu Tufuankenda, Roger Kokusa Zamani, Emmanuel Limbole Baliko, Eleuthère Kintoki Vita, Jean-Réné M'buyamba Kabangu, Benjamin Longo-Mbenza
American Journal of Cardiovascular Disease 2021
Protracted Impairment of Maternal Metabolic Health in Mouse Dams Following Pregnancy Exposure to a Mixture of Low Dose Endocrine-Disrupting Chemicals, a Pilot Study.
Merrill AK, Anderson T, Conrad K, Marvin E, James-Todd T, Cory-Slechta DA, Sobolewski M
Toxics 2021
Examining the Efficacy of a Very-Low-Carbohydrate Ketogenic Diet on Cardiovascular Health in Adults with Mildly Elevated Low-Density Lipoprotein Cholesterol in an Open-Label Pilot Study.
Tzenios N, Lewis ED, Crowley DC, Chahine M, Evans M
Metabolic Syndrome and Related Disorders 2021
Identification of a TMEM182 rs141764639 polymorphism associated with central obesity by regulating tumor necrosis factor-α in a Korean population
M Ma, JH Lee, M Kim
Journal of Diabetes and its Complications 2020
EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)
VV Kukharchuk, MV Ezhov, IV Sergienko, GG Arabidze, TV Balakhonova, VS Gurevich, PA Zelveyan, TM Murataliev, GS Myrzakhmetova, OA Sudzhaeva, AB Shek, VA Azizov, NB Gornyakova, MA Kachkovsky, PP Malyshev, SN Pokrovsky, AA Sokolov, AB Sumarokov, AG Obrezan, II Shaposhnik, MB Antsiferov, AA Ansheles, DM Aronov, NM Akhmedzhanov, OL Barbarash, SA Boytsov, MG Bubnova, MI Voevoda, GR Galstyan, AS Galyavich, OM Drapkina, DV Duplyakov, SY Eregin, RS Karpov, YA Karpov, NA Koziolova, GA Konovalov, VO Konstantinov, ED Kosmacheva, SV Nedogoda, VE Olejnikov, YI Ragino, VV Skibickij, OG Smolenskaya, YS Halimov, IE Chazova, AE Filippov, MV Shestakova, SS Yakushin
2020
Critical Role of SREBP (Sterol Regulatory Element-Binding Protein)-1c Large-VLDL (Very Low-Density Lipoprotein) Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency
M Takanashi, T Kimura, C Li, M Tanaka, A Matsuhashi, H Yoshida, A Noda, P Xu, S Takase, S Okazaki, Y Iizuka, H Kumagai, Y Ikeda, T Gotoda, M Takahashi, H Yagyu, S Ishibashi, T Yamauchi, T Kadowaki, G Liang, H Okazaki
Arteriosclerosis, thrombosis, and vascular biology 2019
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial
F Galletti, V Fazio, M Gentile, G Schillaci, G Pucci, F Battista, V Mercurio, G Bosso, D Bonaduce, N Brambilla, C Vitalini, M DAmato, G Giacovelli
Lipids in Health and Disease 2019
Serum apolipoprotein B is associated with increased risk of metabolic syndrome among middle-aged and elderly Chinese: A cross-sectional and prospective cohort study
R Du, X Wu, K Peng, L Lin, M Li, Y Xu, M Xu, Y Chen, D Li, J Lu, Y Bi, W Wang, G Ning
Journal of Diabetes 2019
Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics
GP Arutyunov, SA Boytsov, MI Voyevoda, VS Gurevich, OM Drapkina, VV Kukharchuk, AI Martynov, IV Sergiyenko, MV Shestakova, AS Aliyeva, NM Akhmedzhanov, MG Bubnova, АS Galyavich, IG Gordeyev, MV Ezhov, YA Karpov, VO Konstantinov, SV Nedogoda, EM Nifontov, YA Orlova, AV Panov, SA Sayganov, VV Skibitskiy, EI Tarlovskaya, SA Urazgildeyeva, YS Khalimov
2019
Correction of hypertriglyceridemia in order to reduce the residual risk in atherosclerosis-related diseases. Expert Council Opinion
GP Arutyunov, SA Boytsov, MI Voevoda, OM Drapkina, VV Kukharchuk, AI Martynov, MV Shestakova, VS Gurevich, IV Sergienko, AS Alieva, NM Akhmedzhanov, MG Bubnova, AS Galyavich, IG Gordeev, MV Yezhov, YA Karpov, VO Konstantinov, SV Nedogoda, EM Nifontov, YA Orlova, AV Panov, SA Saiganov, VV Skibitsky, EI Tarlovskaya, SA Urazgildeeva, YS Khalimov
2019
Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content
X Liang, SW Yee, HC Chien, EC Chen, Q Luo, L Zou, M Piao, A Mifune, L Chen, ME Calvert, S King, F Norheim, J Abad, RM Krauss, KM Giacomini, N Soranzo
PLoS Biology 2018
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
M Kinoshita, K Yokote, H Arai, M Iida, Y Ishigaki, S Ishibashi, S Umemoto, G Egusa, H Ohmura, T Okamura, S Kihara, S Koba, I Saito, T Shoji, H Daida, K Tsukamoto, J Deguchi, S Dohi, K Dobashi, H Hamaguchi, M Hara, T Hiro, S Biro, Y Fujioka, C Maruyama, Y Miyamoto, Y Murakami, M Yokode, H Yoshida, H Rakugi, A Wakatsuki, S Yamashita
Journal of Atherosclerosis and Thrombosis 2018
Biopsychosocial Approaches to Understanding Health in South Asian Americans
MJ Perera, EC Chang
2018
Association of self-reported sedentary time with insulin resistance among Korean adults without diabetes mellitus: a cross-sectional study
KS Kim, SJ Kim, S Kim, DW Choi, YJ Ju, EC Park
BMC Public Health 2018
Insulin resistance in children with familial hyperlipidemia
S Terlemez, E Bozdemir, SK Uçar, C Kabaroğlu, S Habif, M Kayıkçıoğlu, M Çoker
Journal of Pediatric Endocrinology and Metabolism 2018
So What Comes First: The Obesity or the Insulin Resistance? And Which Is More Important?
TD Noakes
Clinical chemistry 2018
Mechanisms of Vascular Defects in Diabetes Mellitus
CC Kartha, S Ramachandran, RM Pillai
Mechanisms of Vascular Defects in Diabetes Mellitus 2017
Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes
DR Pokharel, D Khadka, M Sigdel, NK Yadav, S Acharya, R Kafle, RM Sapkota, T Sigdel
BMC Research Notes 2017
Using the VAP lipid panel for the detection, evaluation, and treatment of patients “at risk” for CAD
K French, Y Wang, J Jia, Y Zhang
Frontiers in Laboratory Medicine 2017
Relevance of the triglyceride-to-high-density lipoprotein cholesterol ratio as an important lipid fraction in apparently healthy, young, and middle-aged Indian men
A Kohli, A Siddhu, RM Pandey, KS Reddy
Indian journal of endocrinology and metabolism 2017
Increased Risk of the APOB rs11279109 Polymorphism for CHD among the Kuwaiti Population
SA Al-Bustan, FG Ismael, A Al-Serri, I Al-Rashdan
Disease Markers 2017
VII. Triglyceride and HDL Cholesterol as Risk Factors and the Treatment Targets for Atherosclerosis
M Ai
Nihon Naika Gakkai Zasshi 2017
A Human Model of Dietary Saturated Fatty Acid Induced Insulin Resistance
J Koska, MK Ozias, J Deer, J Kurtz, AD Salbe, SM Harman, PD Reaven
Metabolism 2016
Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
PD Rosenblit
Cardiovascular Diabetology 2016
Cardiometabolic Risk in South Asian Inhabitants of California: Hypertriglyceridemic Waist vs Hypertriglyceridemic Body Mass Index
F Abbasi, A Mathur, GM Reaven, CR Molina
Ethnicity & disease 2016
Biomarkers in Cardiovascular Disease
A Akyüz
Biomarkers in Cardiovascular Disease 2016
Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men
GL Vega, SM Grundy, CE Barlow, D Leonard, BL Willis, LF DeFina, SW Farrell
Journal of Clinical Lipidology 2016
The Activity of Serum 8-Iso-Prostaglandin F2α as Oxidative Stress Marker in Patients with Diabetes Mellitus Type 2 and Associated Dyslipidemic Hyperglycemia
MH Mukhtar, HM El-Emshaty, HS Alamodi, WA Nasif
Journal of Diabetes Mellitus 2016
Hyperinsulinemia and Insulin Resistance: Scope of the Problem
J Fung, A Berger
Journal of Insulin Resistance 2016
A fatty acid-dependent hypothalamic–DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins
JT Yue, MA Abraham, MP LaPierre, PI Mighiu, PE Light, BM Filippi, TK Lam
Nature Communications 2015
Abnormalities of Lipoprotein Concentrations in Obstructive Sleep Apnea Are Related to Insulin Resistance
A Liu, J Cardell, D Ariel, C Lamendola, F Abbasi, SH Kim, TH Holmes, V Tomasso, H Mojaddidi, K Grove, CA Kushida, GM Reaven
Sleep 2015
Obesity as a Potential Risk Factor for Blepharoptosis: The Korea National Health and Nutrition Examination Survey 2008-2010
JS Paik, SK Jung, KD Han, SD Kim, YM Park, SW Yang, M Madigan
PloS one 2015
Estimation of LDL Particle Size Using Lipid Indices: A Population-Based Study of 1578 Schoolchildren
Y Watabe, O Arisaka, N Miyake, G Ichikawa, S Koyama, N Shimura
Metabolic Syndrome and Related Disorders 2015
Handbook of eggs in human function
KS Kubena
Handbook of eggs in human function 2015
Suppressor of cytokine signaling 3 A+930-->G (rs4969168) polymorphism is associated with apolipoprotein A1 and low-density lipoprotein cholesterol
Tao Guo, Rui-Xing Yin, Rong-Jun Nie, Xia Chen, Yuan Bin, Wei-Xiong Lin
International journal of clinical and experimental pathology 2015
Correlation of lipid metabolic disturbance with SOCS-3 gene variation in the Uygur nationality women in Xinjiang
Jing Hong, Jing Gao, Niluofeier Aierken, Dilinigeer Tuerxun, Mayila Kamilijiang, Nuerguli Maimaiti, Gui-Juan Chang, Nan-Fang Li
International journal of clinical and experimental medicine 2015
Dietary guidelines for saturated fatty acids are not supported by the evidence
PW Parodi, A Lawrence
International dairy journal / published in association with the International Dairy Federation 2015
Nuclear Magnetic Resonance Measured Serum Biomarkers and Type 2 Diabetes Risk Stratification
MA Connelly
2015
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR
J Yu, D Zhai, L Hao, D Zhang, L Bai, Z Cai, C Yu
Evidence-Based Complementary and Alternative Medicine 2014
Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus
E Abd-Allha, BB Hassan, M Abduo, SA Omar, H Sliem
Indian journal of endocrinology and metabolism 2014
Lipoprotein Insulin Resistance Index: A Lipoprotein Particle–Derived Measure of Insulin Resistance
I Shalaurova, MA Connelly, WT Garvey, JD Otvos
Metabolic Syndrome and Related Disorders 2014
Diabetes Mellitus and Human Health Care: A Holistic Approach to Diagnosis and Treatment
M Abhilash, R Augustine
Diabetes Mellitus and Human Health Care: A Holistic Approach to Diagnosis and Treatment 2014
Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies
AM Johri, DK Heyland, MF Hétu, B Crawford, JD Spence
Nutrition, Metabolism and Cardiovascular Diseases 2014
Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes
A Esteghamati, S Asnafi, M Eslamian, S Noshad, M Nakhjavani
Endocrine Research 2014
Gerald M. Reaven, MD: Demonstration of the Central Role of Insulin Resistance in Type 2 Diabetes and Cardiovascular Disease
FB Kraemer, HN Ginsberg
2014
Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: The Circulatory Risk in Communities Study (CIRCS)
H Iso, H Imano, K Yamagishi, T Ohira, R Cui, H Noda, S Sato, M Kiyama, T Okada, S Hitsumoto, T Tanigawa, A Kitamura
Atherosclerosis 2014
Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception
N Plana, D Ibarretxe, A Cabré, E Ruiz, L Masana
Clínica e Investigación en Arteriosclerosis 2014
Hyperinsulinemic syndrome: The metabolic syndrome is broader than you think
CT Kelly, J Mansoor, GL Dohm, WH Chapman, JR Pender, WJ Pories
Surgery 2014
A moderate-fat diet containing pistachios improves emerging markers of cardiometabolic syndrome in healthy adults with elevated LDL levels
SD Holligan, SG West, SK Gebauer, CD Kay, PM Kris-Etherton
British Journal of Nutrition 2014
Iron homeostasis in the liver
ER Anderson, YM Shah
Comprehensive Physiology 2013
Iron homeostasis in the liver
ER Anderson, YM Shah
Comprehensive Physiology 2013
Iron homeostasis in the liver
ER Anderson, YM Shah
Comprehensive Physiology 2013
Cholesterol reduction ameliorates glucose-induced calcium handling and insulin secretion in islets from low-density lipoprotein receptor knockout mice
JC Souza, EC Vanzela, RA Ribeiro, LF Rezende, CA Oliveira, EM Carneiro, HC Oliveira, AC Boschero
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013
Small Dense Low-Density Lipoproteins Cholesterol can Predict Incident Cardiovascular Disease in an Urban Japanese Cohort: The Suita Study
H Arai, Y Kokubo, M Watanabe, T Sawamura, Y Ito, A Minagawa, T Okamura, Y Miyamato
Journal of Atherosclerosis and Thrombosis 2013
Cardiovascular Disease Risk Factors Other than Dyslipidemia
T Teramoto, J Sasaki, S Ishibashi, S Birou, H Daida, S Dohi, G Egusa, T Hiro, K Hirobe, M Iida, S Kihara, M Kinoshita, C Maruyama, T Ohta, T Okamura, S Yamashita, M Yokode, K Yokote
Journal of Atherosclerosis and Thrombosis 2013
The nuances of atherogenic dyslipidemia in diabetes: Focus on triglycerides and current management strategies
PC Manoria, HK Chopra, SK Parashar, AL Dutta, B Pinto, A Mullasari, S Prajapati
Indian Heart Journal 2013
Atherogenic dyslipidemia
CN Manjunath, JR Rawal, PM Irani, K Madhu
Indian journal of endocrinology and metabolism 2013
Insulin Resistance as a Predictor of Cardiovascular Disease in Patients on Peritoneal Dialysis
Y Li, L Zhang, Y Gu, C Hao, T Zhu
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2013
LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease
S Vikarunnessa, MF Weiner, GL Vega
Journal of Alzheimer's disease : JAD 2013
The inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation
MN Islam, SH Choi, HE Moon, JJ Park, HA Jung, MH Woo, HC Woo, JS Choi
European Journal of Nutrition 2013
LDL Phenotype in Subjects with Mild Cognitive Impairment and Alzheimer’s Disease
S Vikarunnessa, MF Weiner, GL Vega
Journal of Alzheimer's disease : JAD 2013
Lipoproteins in Diabetes Mellitus
AJ Jenkins, PP Toth, TJ Lyons
2013
Insulin resistance: Is it time for primary prevention?
V Mercurio, G Carlomagno, V Fazio, S Fazio
World journal of cardiology 2012
Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats
S Kavak, L Ayaz, M Emre
Experimental Diabetes Research 2012
Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia: Metabolic effects of adjunctive aripiprazole
X Fan, CP Borba, P Copeland, D Hayden, O Freudenreich, DC Goff, DC Henderson
Acta Psychiatrica Scandinavica 2012
Small dense low-density lipoprotein particles: priority as a treatment target in Type 2 diabetes?
PA Gerber, GA Spinas, K Berneis
Diabetes Management 2012
Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states :
S Farr, K Adeli
Current Opinion in Lipidology 2012
Dyslipidaemia and age-related involutional blepharoptosis
M Shirado
Journal of Plastic Reconstructive & Aesthetic Surgery 2012
Cholesterol and Triglyceride Concentrations in Lipoproteins as Related to Carotid Intima-Media Thickness
R Takahashi, N Taguchi, M Suzuki, XW Cheng, Y Numaguchi, H Tsukamoto, N Ikeda, T Murohara, K Okumura
International Heart Journal 2012
Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence
KC Maki, HE Bays, MR Dicklin
Journal of Clinical Lipidology 2012
Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction
AC Frazier-Wood, WT Garvey, T Dall, R Honigberg, R Pourfarzib
Metabolic Syndrome and Related Disorders 2012
Energy substrate partitioning and efficiency in individuals with atherogenic lipoprotein phenotype
N Faghihnia, PW Siri-Tarino, RM Krauss, GA Brooks
Obesity (Silver Spring, Md.) 2011
The Metabolic Syndrome
S Devaraj, D Siegel, I Jialal
The Metabolic Syndrome 2011
Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats
V Dhote, A Joharapurkar, S Kshirsagar, N Dhanesha, V Patel, A Patel, S Raval, M Jain
Clinical and Experimental Pharmacology and Physiology 2011
Triglyceride to HDL Ratio is a Reliable Predictor of Adverse Outcomes in Risk Stratification for Candidates Undergoing Abdominal Aortic Surgery
I Gambardella, PH Blair, A McKinley, R Baker, DW Harkin
European Journal of Vascular and Endovascular Surgery 2011
Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo
A Jover, E Corbella, A Muñoz, J Millán, X Pintó, A Mangas, M Zúñiga, J Pedro-Botet, A Hernández-Mijares
Revista Española de Cardiología 2011
Angelica acutiloba Root Attenuates Insulin Resistance Induced by High-Fructose Diet in Rats
IM Liu, TF Tzeng, SS Liou, CJ Chang
Phytotherapy Research 2011
Pathogenic Role of Scavenger Receptor CD36 in the Metabolic Syndrome and Diabetes
DJ Kennedy, SR Kashyap
Metabolic Syndrome and Related Disorders 2011
Fibrate use in diabetes: New concepts
ZT Bloomgarden, A Drexler
Journal of Diabetes 2011
Prevalence of Metabolic Syndrome and its Components in Patients With Acute Coronary Syndrome
A Jover, E Corbella, A Muñoz, J Millán, X Pintó, A Mangas, M Zúñiga, J Pedro-Botet, A Hernández-Mijares
Revista Española de Cardiología (English Edition) 2011
Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects
V Guay, B Lamarche, A Charest, AJ Tremblay, P Couture
Metabolism 2011
Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus
D Tousoulis, K Koniari, C Antoniades, N Papageorgiou, A Miliou, M Noutsou, A Nikolopoulou, K Marinou, E Stefanadi, G Siasos, M Charakida, AM Kamboli, C Stefanadis
International Journal of Cardiology 2011
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes
M Rizzo, GH Tomkin, AM Patti, I Pepe, MR Valerio, SD Rosa, GB Rini, GD Fede
Clinical Lipidology 2011
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick
Williams Textbook of Endocrinology 2011
The Triglyceride to High-Density Lipoprotein–Cholesterol Ratio in Adolescence and Subsequent Weight Gain Predict Nuclear Magnetic Resonance–Measured Lipoprotein Subclasses in Adulthood
R Weiss, JD Otvos, R Sinnreich, AR Miserez, JD Kark
The Journal of Pediatrics 2011
Effects of Insulin Sensitivity, Body Composition, and Fitness on Lipoprotein Particle Sizes and Concentrations Determined by Nuclear Magnetic Resonance
BA Irving, KS Nair, M Srinivasan
The Journal of clinical endocrinology and metabolism 2011
Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
H Gong, Y Du, L Zhong, Z Dong, X Wang, Y Mao, Q Lu
Lipids in Health and Disease 2011
PPAR-γ agonists, insulin resistance and dyslipidemia: not a simple relationship
BR Johns, GM Reaven
Clinical Lipidology 2010
Metabolic and Respiratory Comorbidities of Childhood Obesity
I Fennoy
Pediatric Annals 2010
The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review
KJ Reddy, M Singh, JR Bangit, RR Batsell
Journal of Cardiovascular Medicine 2010
Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?
M Rizzo, K Berneis, S Koulouris, S Pastromas, GB Rini, D Sakellariou, AS Manolis
International Journal of Clinical Practice 2010
Atherogenic dyslipidemia: cardiovascular risk and dietary intervention
K Musunuru
Lipids 2010
Silent ischemia in relation to insulin resistance in normotensive prediabetic adults: early detection by single photon emission computed tomography (SPECT)
G Nasr, H Sliem
The International Journal of Cardiovascular Imaging 2010
Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK
I Oluwatowoju, E Abu, SH Wild, CD Byrne
Diabetic Medicine 2010
Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study
D Tousoulis, K Koniari, C Antoniades, A Miliou, M Noutsou, A Nikolopoulou, N Papageorgiou, K Marinou, E Stefanadi, C Stefanadis
Clinical Therapeutics 2010
Pediatric Non-High-Density Lipoprotein Cholesterol, the Metabolic syndrome, and Insulin Resistance
CJ Glueck, JA Morrison
The Journal of Pediatrics 2010
Dislipidemia en medicina interna
RL M.
Medwave 2010
Surrogate markers of insulin resistance: A review
B Singh
World journal of diabetes 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
N Younis, V Charlton-Menys, R Sharma, H Soran, PN Durrington
Atherosclerosis 2009
Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects
U Masharani, ID Goldfine, JF Youngren
Metabolism: clinical and experimental 2009
Reversal of small, dense LDL subclass phenotype by normalization of adiposity
PW Siri-Tarino, PT Williams, HS Fernstrom, RS Rawlings, RM Krauss
Obesity (Silver Spring, Md.) 2009
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome
T Cascella, S Palomba, F Giallauria, ID Sio, A Colao, G Lombardi, M Orio, F Orio
Clinical Lipidology 2009
Relation between low-density lipoprotein particle size and insulin and diabetes mellitus
O Arisaka, G Ichikawa, S Koyama, N Shimura
The Journal of Pediatrics 2009
Inter-relationship between low-density lipoprotein phenotype and carotid intima-media thickness in North Indian type 2 diabetic subjects
J Ahmad, KJ Farooqui, AR Khan
Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2009
Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles
K Winkler, T Schewe, G Pütz, N Ödünc, G Schäfer, E Siegel, U Geisen, C Abletshauser, MM Hoffmann
European Journal of Clinical Investigation 2009
Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin
M Malaguarnera, M Vacante, M Motta, M Malaguarnera, GL Volti, F Galvano
Metabolism 2009
Cholesterol metabolism and pancreatic β-cell function
M Fryirs, PJ Barter, KA Rye
Current Opinion in Lipidology 2009
Metabolic syndrome: A review of emerging markers and management
B Singh, S Arora, B Goswami, V Mallika
Diabetes and Metabolic Syndrome Clinical Research and Reviews 2009
Early onset of proteinuria and focal segmental glomerulosclerosis in obese, hyperinsulinemic adolescents developing metabolic syndrome
Ron S. Newfield, Ilana Koren, Ladislav Slezak, Geoffrey Boner, Eliezer Rosenmann, Konstantin Bloch, Oscar-Minuhin, Pnina Vardi
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2009
Adiponectin gene single-nucleotide polymorphisms and treatment response to obesity
K Tsuzaki, K Kotani, N Nagai, K Saiga, Y Sano, T Hamada, T Moritani, M Yoshimura, K Egawa, C Horikawa, Y Kitagawa, Y Kiso, N Sakane
Journal of Endocrinological Investigation 2009
Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: Effects on atherogenic lipoprotein phenotype
R Tkacova, M Rizzo, K Berneis
Medical Hypotheses 2009
Metabolic Syndrome Pathophysiology and Clinical Presentation
Y Handelsman
Toxicologic pathology 2009
Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk
K Musunuru, M Orho-Melander, MP Caulfield, S Li, WA Salameh, RE Reitz, G Berglund, B Hedblad, G Engström, PT Williams, S Kathiresan, O Melander, RM Krauss
Arteriosclerosis, thrombosis, and vascular biology 2009
Modern Nutrition
K LaPoint, M McIntosh
Handbook of Nutrition in the Aged, Fourth Edition 2008
Fundamental and Clinical Cardiology Series
PD Stein
Cardiovascular Disease in the Elderly 2008
Effects of Modifying Triglycerides and Triglyceride-rich Lipoproteins on Cardiovascular Outcomes
M Abdel-Maksoud, V Sazonov, SW Gutkin, JE Hokanson
Journal of Cardiovascular Pharmacology 2008
Cardiometabolic risk management in type 2 diabetes and obesity
AM Taylor
Current Diabetes Reports 2008
Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study
T Kaitosaari, O Simell, J Viikari, O Raitakari, M Siltala, M Hakanen, A Leino, E Jokinen, T Rönnemaa
European Journal of Pediatrics 2008
The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats
S Kavak, L Ayaz, M Emre, T Inal, L Tamer, I Günay
Cell Biochemistry and Function 2008
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?
M Rizzo, ER Christ, GB Rini, GA Spinas, K Berneis
Expert Opinion on Pharmacotherapy 2008
Low-Density Lipoprotein Sub-Fraction Profiles in Obese Children Before and After Attending a Residential Weight Loss Intervention
RF King, JP Hobkirk, CB Cooke, D Radley, PJ Gately
Journal of Atherosclerosis and Thrombosis 2008
PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes
I Mertens, I Lemieux, A Verrijken, JP Després, LF van Gaal
Diabetes/Metabolism Research and Reviews 2008
Impaired Glucose Tolerance and Neuropathy
AG Smith, JR Singleton
The Neurologist 2008
Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells
UH Jin, YJ Kang, YC Chang, CH Kim
Journal of Cellular Biochemistry 2008
Apport de la RMN dans l’évaluation du risque cardiovasculaire lié aux dyslipidémies
D Bonnefont-Rousselot, R Bittar, M Atassi, E Bruckert, MJ Chapman
Annales Pharmaceutiques Françaises 2008
Postprandial dyslipidemia in insulin resistance: Mechanisms and role of intestinal insulin sensitivity
J Hsieh, AA Hayashi, J Webb, K Adeli
Atherosclerosis Supplements 2008
Síndrome metabólico, enfermedad cardiovascular y medicina sexual
NC Navarro
Revista Internacional de Andrología 2008
Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study
W Leonhardt, A Pfützner, J Müller, J Pietzsch, T Forst, E Karagiannis, G Lübben, M Hanefeld
Atherosclerosis 2008
Therapeutic Lipidology
MH Davidson, PP Toth, KC Maki, AM Gotto
2008
Nutrition and Rheumatic Disease
LA Coleman
2008
Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins
TK Lam, R Gutierrez-Juarez, A Pocai, S Bhanot, P Tso, GJ Schwartz, L Rossetti
Nature Medicine 2007
The insulin resistance syndrome: physiological considerations
SR Kashyap, RA Defronzo
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2007
Functional dairy products
A Aziz, GH Anderson
Functional dairy products 2007
Pathophysiology and types of dyslipidemia in PCOS
E Diamanti-Kandarakis, AG Papavassiliou, SA Kandarakis, GP Chrousos
Trends in Endocrinology & Metabolism 2007
The metabolic syndrome: metabolic changes with vascular consequences
AM Wassink, JK Olijhoek, FL Visseren
European Journal of Clinical Investigation 2007
Risk Factors of Atherosclerotic Diseases - Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
T Teramoto, J Sasaki, H Ueshima, G Egusa, M Kinoshita, K Shimamoto, H Daida, S Biro, K Hirobe, T Funahashi, K Yokote, M Yokode
Journal of Atherosclerosis and Thrombosis 2007
Small Dense Low-density Lipoprotein Cholesterol is a Useful Marker of Metabolic Syndrome in Patients with Coronary Artery Disease
T Nozue, I Michishita, Y Ishibashi, S Ito, T Iwaki, I Mizuguchi, M Miura, Y Ito, T Hirano
Journal of Atherosclerosis and Thrombosis 2007
Incidence and risk factors of insulin resistance syndrome in 20-59 year-old Korean male workers
SG Kim, HS Lim, HK Cheong, CS Kim, HJ Seo
Journal of Korean Medical Science 2007
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles
IF Gazi, V Tsimihodimos, AD Tselepis, M Elisaf, DP Mikhailidis
Expert Opinion on Biological Therapy 2007
Respuestas cardiovasculares al NaCl hipertónico inyectado en la región anteroventral del tercer ventrículo de ratas con hipertensión e insulinorresistencia inducidas por fructosa
FJ Rosa, E Romero-Vecchione, J Vásquez, R Antequera, M Strauss
Revista Española de Cardiología 2007
Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy
P Berhanu, A Perez, S Yu
Diabetes, Obesity and Metabolism 2007
Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients
M Ohira, Y Miyashita, M Ebisuno, A Saiki, K Endo, N Koide, T Oyama, T Murano, H Watanabe, K Shirai
Diabetes Research and Clinical Practice 2007
Association of Pro12Ala polymorphism in the peroxisome proliferator–activated receptor γ2 gene with small dense low-density lipoprotein in the general population
T Hamada, K Kotani, K Tsuzaki, Y Sano, T Murata, M Tabata, S Sato, N Sakane
Metabolism 2007
Nuclear magnetic resonance–determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus
SY Ding, XT Tigno, BC Hansen
Metabolism 2007
Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus
Y Hayashi, K Okumura, H Matsui, A Imamura, M Miura, R Takahashi, R Murakami, Y Ogawa, Y Numaguchi, T Murohara
Metabolism 2007
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
DC Goff, HC Gerstein, HN Ginsberg, WC Cushman, KL Margolis, RP Byington, JB Buse, S Genuth, JL Probstfield, DG Simons-Morton
The American Journal of Cardiology 2007
Geriatric Diabetes
M Burge, L Gamache, H Pai, A Segal
Geriatric Diabetes 2007
The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome
AI Kakafika, DP Mikhailidis, A Karagiannis, VG Athyros
The Journal of Clinical Pharmacology 2007
The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre?
GM Reaven
Journal of the American College of Nutrition 2007
The Clinical Biochemistry of Obesity—More Than Skin Deep
KA Sikaris
Heart, Lung and Circulation 2007
Type 2 Diabetes: Principles and Practice, Second Edition
L Adams
Type 2 Diabetes: Principles and Practice, Second Edition 2007
A Combination of Psyllium and Plant Sterols Alters Lipoprotein Metabolism in Hypercholesterolemic Subjects by Modifying the Intravascular Processing of Lipoproteins and Increasing LDL Uptake
S Shrestha, HC Freake, MM McGrane, JS Volek, ML Fernandez
The Journal of nutrition 2007
Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk
E Ferrannini, B Balkau, SW Coppack, JM Dekker, A Mari, J Nolan, M Walker, A Natali, H Beck-Nielsen
The Journal of clinical endocrinology and metabolism 2007
Preventive Effect of Diabegon, a Polyherbal Preparation, During Progression of Diabetes Induced by High-Fructose Feeding in Rats
H Yadav, S Jain, GB Prasad, M Yadav
Journal of Pharmacological Sciences 2007
Atherogenic Lipid Phenotype in a General Group of Subjects
J Van, J Pan, MA Charles, R Krauss, N Wong, X Wu
Archives of pathology & laboratory medicine 2007
Generik atorvastatina Tulip? v lechenii dislipidemii u bol'nykh s sakharnym diabetom 2 tipa
AG Zalevskaya, VL Orlova, EM Patrakeeva
Diabetes mellitus 2007
Predominance of Small Dense Low-Density Lipoproteins and Abnormal Glucose Regulation in Patients With Acute Coronary Syndrome
Y Ban, S Koba, F Tsunoda, Y Yokota, H Ezumi, T Kondo, H Suzuki, T Katagiri
Circulation Journal 2006
Diabetic Cardiomyopathy
GC Fonarow, P Srikanthan
Endocrinology & Metabolism Clinics of North America 2006
Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome
G Paragh, I Seres, M Harangi, A Erdei, M Audikovszky, L Debreczeni, A Kovácsay, L Illyés, G Pados
British Journal of Clinical Pharmacology 2006
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials
J Costa, M Borges, C David, AV Carneiro
BMJ (Clinical research ed.) 2006
Should all patients with metabolic syndrome be treated with statins?
N Abate, M Chandalia
Current Diabetes Reports 2006
Lipid and lipoprotein dysregulation in insulin resistant states
RK Avramoglu, H Basciano, K Adeli
Clinica Chimica Acta 2006
Small, dense low-density-lipoproteins and the metabolic syndrome
M Rizzo, K Berneis
Diabetes/Metabolism Research and Reviews 2006
Plasma fatty acids and lipoproteins in type 2 diabetic patients
A Lapolla, G Sartore, GR Rovere, G Romanato, S Zambon, R Marin, E Manzato, D Fedele
Diabetes/Metabolism Research and Reviews 2006
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
CJ Packard
Current Opinion in Lipidology 2006
Effect of Metformin Hydrochloride on Blood Sugar and Lipoprotein Metabolism in Type 2 Diabetes Mellitius Patients
K Sakuma, H Sasaki, T Masaka, S Kanai, M Ohhira, T Oyama, Y Miyashita, K Shirai
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2006
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria
I Gazi, V Tsimihodimos, T Filippatos, E Bairaktari, AD Tselepis, M Elisaf
Metabolism 2006
Relationship of low-density lipoprotein particle size to insulin resistance and intima-media thickness in nondiabetic Koreans
JS Park, J Park, CS Kim, MH Cho, HJ Kim, JH Kim, CW Ahn, KR Kim, BS Cha, SK Lim, HC Lee
Metabolism 2006
Effect of Combination Therapy of Benidipine Hydrochloride and Candesartan Cilexetil on Serum Lipid Metabolism and Blood Pressure in Elderly Hypertensive Patients with Type 2 Diabetes Mellitus
H Sasaki, S Kanai, T Oyama, Y Miyashita, S Yamamura, K Shirai
Journal of Atherosclerosis and Thrombosis 2006
Alteraciones lipídicas y riesgo cardiovascular asociado a la terapia antirretroviral
M Masiá-Canuto, E Bernal-Morell, F Gutiérrez-Rodero
Enfermedades Infecciosas y Microbiología Clínica 2006
Metabolic Syndrome and Heart Failure
T Thethi, C Bratcher, V Fonseca
Heart Failure Clinics 2006
Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy
EJ Jeyarajah, WC Cromwell, JD Otvos
Clinics in Laboratory Medicine 2006
Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients
CH Tseng, CP Tseng, CK Chong, JC Cheng, TY Tai
International Journal of Cardiology 2006
Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans
A Vedala, W Wang, RA Neese, MP Christiansen, MK Hellerstein
Journal of lipid research 2006
Quantitative trait loci influencing low density lipoprotein particle size in African Americans
IJ Kullo, K Ding, E Boerwinkle, ST Turner, M Andrade
Journal of lipid research 2006
Visceral obesity is associated with higher urinary albumin excretion levels in normoalbuminuric type 2 diabetic patients
M Pecis, LM Zaslavsky, FB Mallmann, L Pante, AL Krahe, FF Stringhari, LH Canani
Arquivos brasileiros de endocrinologia e metabologia 2006
The metabolic syndrome: is this diagnosis necessary?
GM Reaven
The American journal of clinical nutrition 2006
Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults
T McLaughlin, S Carter, C Lamendola, F Abbasi, G Yee, P Schaaf, M Basina, G Reaven
The American journal of clinical nutrition 2006
Disparate LDL Phenotypic Classification among 4 Different Methods Assessing LDL Particle Characteristics
W Ensign, N Hill, CB Heward
Clinical chemistry 2006
THE INSULIN RESISTANCE SYNDROME: Definition and Dietary Approaches to Treatment
GM Reaven
Annual Review of Nutrition 2005
Influence of dietary carbohydrate and fat on LDL and HDL particle distributions
PW Siri, RM Krauss
Current Atherosclerosis Reports 2005
PON1 polymorphism, diabetes mellitus, obesity, and risk of myocardial infarction: Modifying effect of diabetes mellitus and obesity on the association between PON1 polymorphism and myocardial infarction
J Li, X Wang, Y Huo, T Niu, C Chen, G Zhu, Y Huang, D Chen, X Xu
Genetics in Medicine 2005
Incidence of Metabolic Syndrome and Insulin Resistance in a Population with Organic Erectile Dysfunction
TC Bansal, AT Guay, J Jacobson, BO Woods, RW Nesto
The Journal of Sexual Medicine 2005
Fructose, insulin resistance, and metabolic dyslipidemia
H Basciano, L Federico, K Adeli
Nutrition & Metabolism 2005
Insulin resistance, LDL particle size, and LDL susceptibility to oxidation in pediatric kidney and liver recipients
A Siirtola, M Antikainen, M Ala-Houhala, AM Koivisto, T Solakivi, SM Virtanen, H Jokela, T Lehtimaki, C Holmberg, MK Salo
Kidney International 2005
The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension
PA Sarafidis, AN Lasaridis, PM Nilsson, TF Mouslech, AD Hitoglou-Makedou, PC Stafylas, KA Kazakos, JG Yovos, AA Tourkantonis
Metabolism 2005
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study
DC Goff, RB D'Agostino, SM Haffner, JD Otvos
Metabolism 2005
Association of low-density lipoprotein particle size distribution and cardiovascular risk factors in children
M Kojima, H Kanno, Y Yamazaki, S Koyama, S Kanazawa, O Arisaka
Acta Paediatrica 2005
Evaluating the Cardiovascular Effects of the Thiazolidinediones and Their Place in the Management of Type 2 Diabetes in Relation to the Metabolic Syndrome
AJ Drexler, RW Nesto, MJ Abrahamson, G Bakris, D Bell, J Brunzell, P Dandona, J Davidson, V Fonseca, M Fowler, R Frye, T Giles, S Haffner, N Hollenberg, W Hsueh, R Law, J Plutzky, R Ratner, J Reusch, A Selwyn, J Sowers, K Wyne, LH Young
Metabolic Syndrome and Related Disorders 2005
Is There a Simple Way to Identify Insulin-Resistant Individuals at Increased Risk of Cardiovascular Disease?
T McLaughlin, G Reaven, F Abbasi, C Lamendola, M Saad, D Waters, J Simon, RM Krauss
The American Journal of Cardiology 2005
Compensatory Hyperinsulinemia and the Development of an Atherogenic Lipoprotein Profile: The Price Paid to Maintain Glucose Homeostasis in Insulin-Resistant Individuals
GM Reaven
Endocrinology and metabolism clinics of North America 2005
The metabolic syndrome: A vascular perspective
JT Tamsma, IM Jazet, ED Beishuizen, AJ Fogteloo, AE Meinders, MV Huisman
European Journal of Internal Medicine 2005
Effect of simvastatin on the oxidation of native and modified lipoproteins
G Sobal, H Sinzinger
Biochemical Pharmacology 2005
Principles of Molecular Cardiology
MS Runge, C Patterson
2005
The Metabolic Syndrome: Requiescat in Pace
GM Reaven
Clinical chemistry 2005
Metabolic Syndrome Amplifies the LDL-Cholesterol Associated Increases in Carotid Atherosclerosis
R KAWAMOTO, H TOMITA, Y OKA, A KODAMA, A KAMITANI
Internal Medicine 2005
Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome
MC Garin, B Kalix, A Morabia, RW James
The Journal of clinical endocrinology and metabolism 2005
Counterpoint: Just Being Alive Is Not Good Enough
G Reaven
Clinical chemistry 2005
Distribution of LDL Particle Size in a Population-Based Sample of Children and Adolescents and Relationship with Other Cardiovascular Risk Factors
S Stan, E Levy, EE Delvin, JA Hanley, B Lamarche, J OLoughlin, G Paradis, M Lambert
Clinical chemistry 2005
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals
G Reaven
Endocrinology & Metabolism Clinics of North America 2004
Associations of low density lipoprotein particle composition with atherogenicity
AT Lada, LL Rudel
Current Opinion in Lipidology 2004
Metabolic abnormalities: triglyceride and low-density lipoprotein
RM Krauss, PW Siri
Endocrinology & Metabolism Clinics of North America 2004
The clinical biochemistry of obesity
KA Sikaris
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2004
Low Density Lipoprotein-Heterogenität als prognostischer Marker kardiovaskulärer Erkrankungen / Low density lipoprotein heterogeneity for risk evaluation of cardiovascular disease
K Winkler
LaboratoriumsMedizin 2004
Effects of Fluvastatin in Type 2 Diabetic Patients with Hyperlipidemia: Reduction in Cholesterol Oxidation Products and VCAM-1
JZ Guan, H Murakami, K Yamato, J Tanabe, J Matsui, N Tamasawa, T Suda
Journal of Atherosclerosis and Thrombosis 2004
Low-density lipoprotein particle number and risk for cardiovascular disease
WC Cromwell, JD Otvos
Current Atherosclerosis Reports 2004
Insulin Resistance and Fasting Hyperinsulinemia Are Risk Factors for New Cardiovascular Events in Patients With Prior Coronary Artery Disease and Normal Glucose Tolerance
M Yanase, F Takatsu, T Tagawa, T Kato, K Arai, M Koyasu, H Horibe, S Nomoto, K Takemoto, S Shimizu, M Watarai
Circulation Journal 2004
LDL heterogeneity revisited: lesson for the metabolic syndrome from a new interpopulation study?
DC Chan, GF Watts
European Journal of Clinical Investigation 2004
A new approach to the quantitative measurement of dense LDL subfractions
G Berg, ML Muzzio, R Wikinski, L Schreier
Nutrition, Metabolism and Cardiovascular Diseases 2004
Antidiabetic and hypolipidemic potential of DRF 2519—a dual activator of PPAR-α and PPAR-γ
R Chakrabarti, P Misra, RK Vikramadithyan, M Premkumar, J Hiriyan, SR Datla, RK Damarla, J Suresh, R Rajagopalan
European Journal of Pharmacology 2004
Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type ii diabetes mellitus
H Fukushima, S Sugiyama, O Honda, S Koide, S Nakamura, T Sakamoto, M Yoshimura, H Ogawa, D Fujioka, K Kugiyama
Journal of the American College of Cardiology 2004
Pharmacological treatment of lipid disorders in diabetes
WV Brown
International Journal of Clinical Practice 2004
Hiperlipidemias secundarias. Mecanismos etiopatogénicos. Impacto vascular y tisular de las hiperlipidemias. Historia natural
RB Aguar, AC Lagunas, MC Liarte, PG García
Medicine - Programa de Formación Médica Continuada Acreditado 2004
Síndrome metabólico
FC Murillo, E Meriño-Ibarra, JM Duarte, JA López-Oliva
Medicine - Programa de Formación Médica Continuada Acreditado 2004
Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease
K Shimada, T Kawarabayashi, A Tanaka, D Fukuda, Y Nakamura, M Yoshiyama, K Takeuchi, T Sawaki, K Hosoda, J Yoshikawa
Diabetes Research and Clinical Practice 2004
Insulin resistance increases circulating malondialdehyde-modified LDL and impairs endothelial function in healthy young men
T Mizuno, H Matsui, A Imamura, Y Numaguchi, K Sakai, T Murohara, K Okumura
International Journal of Cardiology 2004
Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations
Y Bossé, L Pérusse, MC Vohl
Journal of lipid research 2004
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
V Fonseca, C Desouza, S Asnani, I Jialal
Endocrine reviews 2004
What is the Relationship Between Exercise and Metabolic Abnormalities?: A Review of the Metabolic Syndrome
S Carroll, M Dudfield
Sports Medicine 2004
Clinical and biochemical manifestations of syndrome X in obese children
E Papadopoulou-Alataki, K Papadopoulou-Legbelou, L Doukas, K Karatzidou, A Pavlitou-Tsiontsi, E Pagkalos
European Journal of Pediatrics 2004
The Cochrane Database of Systematic Reviews
L Hooper, C Bartlett, SG Davey, S Ebrahim
The Cochrane Database of Systematic Reviews 2003
The insulin resistance syndrome
GM Reaven
Current Atherosclerosis Reports 2003
Dyslipidaemia
P Durrington
The Lancet 2003
Triglycerides, High-Density Lipoprotein Cholesterol, and Risk of Ischemic Heart Disease: A View from the Copenhagen Male Study
J Jeppesen
Metabolic Syndrome and Related Disorders 2003
Hyperphagia modifies FA profiles of plasma phospholipids, plasma FFA, and adipose tissue TAG
GV Skuladottir, PI Olason, L Jonsson, JO Skarphedinsson, VH Eriksdottir, PT Atlason, L Franzson, HB Schiöth
Lipids 2003
Small, dense low-density lipoprotein: Risk or myth?
NA Le
Current Atherosclerosis Reports 2003
Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients
JW Chu, F Abbasi, GW Beatty, M Khalili, J Koch, A Rosen, JM Schmidt, JD Stansell, GM Reaven
Metabolism 2003
The insulin resistance syndrome and coronary artery disease
DM Kendall, BE Sobel, AM Coulston, AL Harmel, BK McLean, V Peragallo-Dittko, JB Buse, VA Fonseca, JO Hill, RW Nesto, XF Sunyer
Coronary Artery Disease 2003
Bibliography
&NA;
Coronary Artery Disease 2003
Sophisticated Tests for Susceptibility to Atherosclerosis:An Added Value for Heart Hospitals
HR Superko
The American Heart Hospital Journal 2003
New developments in type 2 diabetes mellitus: Combination therapy with a thiazolidinedione
S Braunstein
Clinical Therapeutics 2003
LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease
A Slowik, T Iskra, W Turaj, J Hartwich, A Dembinska-Kiec, A Szczudlik
Journal of the Neurological Sciences 2003
Genetic disorders of lipoprotein transport in children
SB Clauss, PO Kwiterovich
Progress in Pediatric Cardiology 2003
Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance
CY Tuan, F Abbasi, C Lamendola, T McLaughlin, G Reaven
The American Journal of Cardiology 2003
The plurimetabolic syndrome: qualitative lipoprotein abnormalities and atherosclerosis
A Zambon, G Crepaldi
International Congress Series 2003
The central role of fat and effect of peroxisome proliferator-activated receptor–γ on progression of insulin resistance and cardiovascular disease
WA Hsueh, R Law
The American Journal of Cardiology 2003
Insulin resistance, inflammation, and the prediabetic state
SM Haffner
The American Journal of Cardiology 2003
Handbook of Obesity: Etiology and Pathophysiology, Second Edition
R Pasquali, V Vicennati, U Pagotto
Handbook of Obesity: Etiology and Pathophysiology, Second Edition 2003
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome*
DE FACE
Endocrine Practice 2003
Síndrome metabólico, resistencia a la insulina y metabolismo tisular
BE de Morentin, MC Rodríguez, JA Martínez
Endocrinología y Nutrición 2003
Long-term effect of reduced carbohydrate or increased fiber intake on LDL particle size and HDL composition in subjects with type 2 diabetes
TM Wolever, EB Tsihlias, MI McBurney, NA Le
Nutrition Research 2003
The polymorphism of the β3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size
K Okumura, H Matsui, Y Ogawa, R Takahashi, K Matsubara, H Imai, A Imamura, T Mizuno, M Tsuzuki, Y Kitamura
Metabolism 2003
Atherosclerosis in Type 2 Diabetes Mellitus: The Role of Insulin Resistance
KE Watson, AL Harmel, G Matson
Journal of cardiovascular pharmacology and therapeutics 2003
Nutrition and genetics: an expanding frontier
RE Olson
The American journal of clinical nutrition 2003
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
PT Williams, HR Superko, WL Haskell, EL Alderman, PJ Blanche, LG Holl, RM Krauss
Arteriosclerosis, thrombosis, and vascular biology 2003
Multiple Lipoprotein Abnormalities Associated with Insulin Resistance in Healthy Volunteers Are Identified by the Vertical Auto Profile-II Methodology
JW Chu, F Abbasi, KR Kulkarni, C Lamendola, TL McLaughlin, JN Scalisi, GM Reaven
Clinical chemistry 2003
Effect of Metformin and Sulfonylurea on C-Reactive Protein Level in Well-Controlled Type 2 Diabetics with Metabolic Syndrome
DH Akbar
Endocrine 2003
Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study)
V Sigurdardottir, B Fagerberg, J Hulthe
Journal of Internal Medicine 2002
Relationship between obesity, insulin resistance, and coronary heart disease risk
F Abbasi, BW Brown, C Lamendola, T McLaughlin, GM Reaven
Journal of the American College of Cardiology 2002
Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner
D Panarotto, P Remillard, L Bouffard, P Maheux
European Journal of Clinical Investigation 2002
Insulin Resistance and Endothelial Dysfunction in Atherosclerosis: Implications and Interventions
P Dandona
Diabetes Technology & Therapeutics 2002
Microalbuminuria in hypertension is not a determinant of insulin resistance
I Toft, KH Bonaa, J Eikrem, AL Bendiksen, H Iversen, T Jenssen
Kidney International 2002
NAD(P)H Oxidase p22 Phox C242T Polymorphism Affects LDL Particle Size and Insulin Resistance in Japanese Subjects
R Hayaishi-Okano, Y Yamasaki, K Ohtoshi, T Yasuda, N Katakami, T Hirano, G Yoshino, Y Kajimoto, M Hori
Journal of Atherosclerosis and Thrombosis 2002
Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes
S Koba, T Hirano, G Yoshino, K Sakai, T Sakaue, M Adachi, T Katagiri
Atherosclerosis 2002
Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study
M Pirro, P Mauriège, A Tchernof, B Cantin, GR Dagenais, JP Després, B Lamarche
Atherosclerosis 2002
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia
GM Reaven
Diabetes, Obesity and Metabolism 2002
Postprandial Elevation of Remnant Lipoprotein Leads to Endothelial Dysfunction
J Funada, M Sekiya, M Hamada, K Hiwada
Circulation Journal 2002
Functional foods, blood lipids and coronary heart disease
KG Jackson, JA Lovegrove
Food Science & Technology Bulletin: Functional Foods 2002
Small LDL and Its Clinical Importance as a New CAD Risk Factor: A Female Case Study
HR Superko, M Nejedly, B Garrett
Progress in Cardiovascular Nursing 2002
Obesity and cardiovascular disease
P Poirier, RH Eckel
Current Atherosclerosis Reports 2002
Effects of a low-calorie, low-salt diet and treadmill exercise on atherosclerotic risk factors in obese African-American women
OS Randall, HB Feseha, TM Retta, CN Bettencourt, S Xu, M Ketete, AR Maqbool
The American Journal of Cardiology 2002
High-density lipoproteins and atherosclerosis
DJ Rader
The American Journal of Cardiology 2002
Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome
JE Reusch
The American Journal of Cardiology 2002
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
PO Kwiterovich
The American Journal of Cardiology 2002
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance
SM Haffner
The American Journal of Cardiology 2002
Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus
PN Weissman
The American Journal of Cardiology 2002
Medical Management of Diabetes and Heart Disease
M LeWinter
Medical Management of Diabetes and Heart Disease 2002
Medical Management of Diabetes and Heart Disease: Syndrome X
G Reaven
Medical Management of Diabetes and Heart Disease 2002
Mechanisms in the Development of Type 2 Diabetes Mellitus:
L Quinn
The Journal of cardiovascular nursing 2002
Bases genéticas de la enfermedad coronaria
F Navarro-López
Revista Española de Cardiología 2002
Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease
K Shinohara, T Shoji, M Emoto, H Tahara, H Koyama, E Ishimura, T Miki, T Tabata, Y Nishizawa
Journal of the American Society of Nephrology : JASN 2002
The Medical Risks of Obesity
FX Pi-Sunyer
Obesity Surgery 2002
AGA technical review on obesity
S Klein, T Wadden, HJ Sugerman
Gastroenterology 2002
Insulin improves fasting and postprandial lipemia in type 2 diabetes
C Geltner, M Lechleitner, B Föger, A Ritsch, H Drexel, JR Patsch
European Journal of Internal Medicine 2002
Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease
S Koba, T Hirano, T Kondo, M Shibata, H Suzuki, M Murakami, E Geshi, T Katagiri
American Heart Journal 2002
Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia
J Vakkilainen, P Pajukanta, RM Cantor, IO Nuotio, S Lahdenperä, K Ylitalo, J Pihlajamäki, PT Kovanen, M Laakso, JS Viikari, L Peltonen, MR Taskinen
European Journal of Human Genetics 2002
Metabolic origins and clinical significance of LDL heterogeneity
KK Berneis, RM Krauss
Journal of lipid research 2002
Adiposity, insulin and lipid metabolism in post-menopausal women
JA Lovegrove, KD Silva, JW Wright, CM Williams
International Journal of Obesity 2002
Metabolic effects of nandrolone decanoate and resistance training in men with HIV
FR Sattler, ET Schroeder, MP Dube, SV Jaque, C Martinez, PJ Blanche, S Azen, RM Krauss
American journal of physiology. Endocrinology and metabolism 2002
Low-density lipoprotein particle size, central obesity, cardiovascular fitness and insulin resistance syndrome markers in obese youths
HS Kang, B Gutin, P Barbeau, MS Litaker, J Allison, NA Le
International Journal of Obesity 2002
The Key to an Enigma: How Do Dietary Polyunsaturated Fatty Acids Lower Serum Cholesterol?
RE Olson
The Journal of nutrition 2002
Fructose, weight gain, and the insulin resistance syndrome
SS Elliott, NL Keim, JS Stern, K Teff, PJ Havel
The American journal of clinical nutrition 2002
Pioglitazone reduces atherogenic dense low density lipoprotein (LDL) particles in patients with type 2 diabetes mellitus
K Winkler, I Friedrich, MW Baumstark, H Wieland, W März
The British Journal of Diabetes & Vascular Disease 2002
Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover
BW Patterson, B Mittendorfer, N Elias, R Satyanarayana, S Klein
Journal of lipid research 2002
Distribution and correlates of lipoproteins and their subclasses in black and white young adults. The Bogalusa Heart Study
SR Srinivasan, JP Segrest, AM Elkasabany, GS Berenson
Atherosclerosis 2001
Selective aspects of the insulin resistance syndrome
DB Corry, ML Tuck
Current Opinion in Nephrology and Hypertension 2001
Syndrome X
G Reaven
Current Treatment Options in Cardiovascular Medicine 2001
Emergence of Obesity and Cardiovascular Risk for Coronary Artery Disease: The Bogalusa Heart Study
GS Berenson, SR Srinivasan
Preventive Cardiology 2001
Current Lipid-lowering Strategies for the Treatment of Diabetic Dyslipidemia: An Integrated Approach to Therapy
A Marcus
The Endocrinologist 2001
Smaller LDL particle size in women with polycystic ovary syndrome compared to controls
S Dejager, C Pichard, P Giral, E Bruckert, MC Federspield, I Beucler, G Turpin
Clinical Endocrinology 2001
Hyperinsulinemia as a Risk Factor for Restenosis After Coronary Balloon Angioplasty
M Imazu, K Sumii, H Yamamoto, M Toyofuku, T Okimoto, Y Gomyo, H Ueda, Y Hayashi, N Kohno
Japanese Circulation Journal 2001
DIETARY ANDGENETICEFFECTS ONLOW-DENSITYLIPOPROTEINHETEROGENEITY
RM Krauss
Annual Review of Nutrition 2001
Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection
PG Cohen
Medical Hypotheses 2001
Insulin resistance syndrome and type 2 diabetes mellitus
DW Erkelens
The American Journal of Cardiology 2001
Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X
G Reaven, K Segal, J Hauptman, M Boldrin, C Lucas
The American Journal of Cardiology 2001
Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy
HN Ginsberg
The American Journal of Cardiology 2001
Nutrition in the Prevention and Treatment of Disease
JM Ordovas
Nutrition in the Prevention and Treatment of Disease 2001
Hepatic Very Low Density Lipoprotein-ApoB Overproduction Is Associated with Attenuated Hepatic Insulin Signaling and Overexpression of Protein-tyrosine Phosphatase 1B in a Fructose-fed Hamster Model of Insulin Resistance
C Taghibiglou, F Rashid-Kolvear, SC van Iderstine, H Le-Tien, IG Fantus, GF Lewis, K Adeli
The Journal of biological chemistry 2001
Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance
K Adeli, C Taghibiglou, SC van Iderstine, GF Lewis
Trends in Cardiovascular Medicine 2001
Serum Triglycerides and Risk of Coronary Heart Disease among Japanese Men and Women
H Iso, Y Naito, S Sato, A Kitamura, T Okamura, T Sankai, T Shimamoto, M Iida, Y Komachi
American Journal of Epidemiology 2001
Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women
HS Kim, F Abbasi, C Lamendola, T McLaughlin, GM Reaven
The American journal of clinical nutrition 2001
Atherogenic Lipoprotein Phenotype and Diet-Gene Interactions
RM Krauss
The Journal of nutrition 2001
Cardiovascular Risk Factors Associated With Insulin Resistance Cluster in Families With Early-Onset Coronary Heart Disease
A Kareinen, L Viitanen, P Halonen, S Lehto, M Laakso
Arteriosclerosis, thrombosis, and vascular biology 2001
Diet and syndrome X
GM Reaven
Current Atherosclerosis Reports 2000
Low density lipoprotein particle size and risk factors of insulin resistance syndrome
Y Friedlander, M Kidron, M Caslake, T Lamb, M McConnell, H Bar-On
Atherosclerosis 2000
Reverse cholesterol transport in diabetes mellitus
EC Quintão, WL Medina, M Passarelli
Diabetes/Metabolism Research and Reviews 2000
High-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus
W Medina
European Journal of Internal Medicine 2000
Obesity and the metabolic syndrome: the San Antonio Heart Study
SM Haffner
British Journal of Nutrition 2000
Pathogenesis of vascular disease
J Colwell
Diabetes, Obesity and Metabolism 2000
Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women
PS MacLean, S Vadlamudi, KG MacDonald, WJ Pories, JA Houmard, HA Barakat
Metabolism 2000
The db/db mouse, a model for diabetic dyslipidemia: Molecular characterization and effects of western diet feeding
K Kobayashi, TM Forte, S Taniguchi, BY Ishida, K Oka, L Chan
Metabolism 2000
Functional foods
JA Lovegrove, KG Jackson
Functional foods 2000
MANAGEMENT OF SELECTED LIPID ABNORMALITIES
DJ Rader, S Rosas
Medical Clinics of North America 2000
Raising low levels of high-density lipoprotein cholesterol is an important target of therapy
WE Boden, TA Pearson
The American Journal of Cardiology 2000
Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension
KI Ryomoto, M Suzuki, A Kanazawa, M Hasegawa, Y Kimura, T Yamamura, Y Harano
American Journal of Hypertension 2000
Low-Density Lipoprotein Subclass Distribution Pattern and Adiposity-Associated Dyslipidemia in Postmenopausal Women
KC Maki, MH Davidson, MS Cyrowski, AC Maki, P Marx
Journal of the American College of Nutrition 2000
Preventing, stopping, or reversing coronary artery disease— triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: The need for recognition and treatment
EE Ferguson
Disease-a-Month 2000
The role of small, dense low density lipoprotein (LDL): a new look
C Packard, M Caslake, J Shepherd
International Journal of Cardiology 2000
Mechanisms of Hepatic Very Low Density Lipoprotein Overproduction in Insulin Resistance: EVIDENCE FOR ENHANCED LIPOPROTEIN ASSEMBLY, REDUCED INTRACELLULAR ApoB DEGRADATION, AND INCREASED MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IN A FRUCTOSE-FED HAMSTER MODEL
C Taghibiglou, A Carpentier, SC van Iderstine, B Chen, D Rudy, A Aiton, GF Lewis, K Adeli
The Journal of biological chemistry 2000
Lack of association between lipaemia and central adiposity in subjects with an atherogenic lipoprotein phenotype (ALP)
AM Minihane, S Khan, PJ Talmud, DL Williams, JW Wright, MC Murphy, BA Griffin, CM Williams
International Journal of Obesity 2000
Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects
S Bioletto, A Golay, R Munger, B Kalix, RW James
The American journal of clinical nutrition 2000
Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns
DM Dreon, HA Fernstrom, PT Williams, RM Krauss
The American journal of clinical nutrition 2000
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis: The Atherosclerosis and Insulin Resistance (AIR) Study
J Hulthe, L Bokemark, J Wikstrand, B Fagerberg
Arteriosclerosis, thrombosis, and vascular biology 2000
High Triglycerides and Low HDL Cholesterol and Blood Pressure and Risk of Ischemic Heart Disease
J Jeppesen, HO Hein, P Suadicani, F Gyntelberg
Hypertension 2000
Endothelial Dysfunction in Men With Small LDL Particles
J Vakkilainen, S Mäkimattila, A Seppälä-Lindroos, S Vehkavaara, S Lahdenperä, PH Groop, MR Taskinen, H Yki-Järvinen
Circulation 2000
Obesity: Pathology and Therapy
DH Lockwood, TC Heffner
2000
Diabetic dyslipidaemia
Betteridge
European Journal of Clinical Investigation 1999
Endothelial dysfunction, insulin resistance and diabetes: exploring the web of causality
D Playford, GF Watts
Australian and New Zealand Journal of Medicine 1999
Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk?
LK Summers, JS Samra, KN Frayn
Atherosclerosis 1999
Obesity and diabetes
KS Leong, JP Wilding
Best Practice & Research Clinical Endocrinology & Metabolism 1999
LDL particle size: an important drug target?
I Rajman, PI Eacho, PJ Chowienczyk, JM Ritter
British Journal of Clinical Pharmacology 1999
Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men
I Lemieux, A Pascot, A Tchernof, J Bergeron, D Prud'homme, C Bouchard, JP Després
Metabolism 1999
Comorbidities of overweight and obesity: current evidence and research issues
FX Pi-Sunyer
Medicine & Science in Sports & Exercise 1999
Relationship between the apolipoprotein E and angiotensin-converting enzyme genotypes and LDL particle size in Japanese subjects
K Okumura, H Matsui, K Kawakami, Y Numaguchi, S Kaneko, I Morishima, S Mokuno, Y Toki, T Hayakawa
Clinica Chimica Acta 1999
Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia
L Patti, A Maffettone, C Iovine, LD Marino, G Annuzzi, G Riccardi, AA Rivellese
Atherosclerosis 1999
The Potential Influence of Insulin and Plasminogen Activator Inhibitor Type 1 on the Formation of Vulnerable Atherosclerotic Plaques Associated with Type 2 Diabetes
BE Sobel
Proceedings of The Association of American Physicians 1999
Hyperinsulinemia in a normal population as a predictor of non—insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The barilla factory revisited
I Zavaroni, L Bonini, P Gasparini, AL Barilli, A Zuccarelli, E Dall'Aglio, R Delsignore, GM Reaven
Metabolism 1999
Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype
MA Austin, K Stephens, CE Walden, E Wijsman
Atherosclerosis 1999
The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy
DN O’Neal, FL Hew, JD Best, F Alford
Growth Hormone & IGF Research 1999
Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?
R Scott, CJ Lintott, P Zimmet, L Campbell, K Bowen, T Welborn
Diabetes Research and Clinical Practice 1999
Improving the Adverse Cardiovascular Prognosis of Type 2 Diabetes
JH O'Keefe, JM Miles, WH Harris, RM Moe, BD McCallister
Mayo Clinic Proceedings 1999
Epidemiology of insulin resistance and its relation to coronary artery disease
SM Haffner
The American Journal of Cardiology 1999
Insulin resistance and lipid metabolism
BV Howard
The American Journal of Cardiology 1999
Atherosclerotic disease in non–insulin-dependent diabetes mellitus: Role of abnormal lipids and the place for lipid-altering therapies
DG Orloff, MA Blazing, CM O’Connor
American Heart Journal 1999
Managing Dyslipidemia in Older Adults1
CM Carlsson, M Carnes, PE McBride, JH Stein
Journal of the American Geriatrics Society 1999
Effects of troglitazone on atherogenic lipoprotein phenotype in coronary patients with insulin resistance
S Sunayama, Y Watanabe, H Ohmura, M Sawano, K Shimada, H Mokuno, H Daida, H Yamaguchi
Atherosclerosis 1999
Melancholic Depression and Abdominal Fat Distribution: A Mini-Review
JN Mann, JH Thakore
Stress (Amsterdam, Netherlands) 1999
LDL Size in African Americans, Hispanics, and Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study
SM Haffner, R DAgostino, D Goff, B Howard, A Festa, MF Saad, L Mykkänen
Arteriosclerosis, thrombosis, and vascular biology 1999
Glucose Phosphorylation Is Essential for the Turnover of Neutral Lipid and the Second Stage Assembly of Triacylglycerol-Rich ApoB-Containing Lipoproteins in Primary Hepatocyte Cultures
AM Brown, D Wiggins, GF Gibbons
Arteriosclerosis, thrombosis, and vascular biology 1999
Increased Plasminogen Activator Inhibitor-1 and Vasculopathy: A Reconcilable Paradox
BE Sobel
Circulation 1999
Low-Density Lipoprotein Particle Size Is Inversely Related to Plasminogen Activator Inhibitor-1 Levels: The Insulin Resistance Atherosclerosis Study
A Festa, R DAgostino, L Mykkänen, R Tracy, BV Howard, SM Haffner
Arteriosclerosis, thrombosis, and vascular biology 1999
Chest Pain with Normal Coronary Angiograms: Pathogenesis, Diagnosis and Management
JC Kaski
1999
Contemporary Concepts in Cardiology
R Gorlin, G Dangas, PK Toutouzas, MM Konstadoulakis
1999
The Management of Eating Disorders and Obesity
DJ Goldstein
1999
Fasting Remnant Lipoprotein Cholesterol and Triglyceride Concentrations Are Elevated in Nondiabetic, Insulin-Resistant, Female Volunteers1
F Abbasi, T McLaughlin, C Lamendola, H Yeni-Komshian, A Tanaka, T Wang, K Nakajima, GM Reaven
The Journal of clinical endocrinology and metabolism 1999
Increased Ability of LDL from Normolipidemic Type 2 Diabetic Women to Generate Peroxides
B Guerci, H Antebi, L Meyer, V Durlach, O Ziegler, JP Nicolas, LG Alcindor, P Drouin
Clinical chemistry 1999
Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men
SC Riemens, AV Tol, BK Stulp, RP Dullaart
Journal of lipid research 1999
Insulin Resistance and Human Disease: A Short History
GM Reaven
Journal of Basic and Clinical Physiology and Pharmacology 1998
Lipoprotein composition and serum apolipoproteins in normoglycaemic first-degree relatives of non-insulin dependent diabetic patients
MW Stewart, DB Humphriss, J Mitcheson, J Webster, M Walker, MF Laker
Atherosclerosis 1998
Defects of lipoprotein metabolism in familial combined hyperlipidaemia
J Graaf, AF Stalenhoef
Current Opinion in Lipidology 1998
INSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE
SJ Cleland, JR Petrie, S Ueda, HL Elliott, JM Connell
Clinical and Experimental Pharmacology and Physiology 1998
Modulation of LDL particle size after an oral glucose load is associated with insulin levels
K Okumura, H Matsui, K Kawakami, I Morishima, Y Numaguchi, K Murase, Y Toki, T Ito
Clinica Chimica Acta 1998
Glucose intolerance in familial combined hyperlipidaemia
Vakkilainen, Porkka, Nuotio, Pajukanta, Suurinkeroinen, Ylitalo, Viikari, Ehnholm, Taskinen
European Journal of Clinical Investigation 1998
The association between dyslipidaemia and obesity in Chinese men after adjustment for insulin resistance
GT Ko, JC Chan, CS Cockram
Atherosclerosis 1998
High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia
T Hirano, K Oi, S Sakai, K Kashiwazaki, M Adachi, G Yoshino
Atherosclerosis 1998
Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects
DN O'Neal, J Lewicki, MZ Ansari, PG Matthews, JD Best
Atherosclerosis 1998
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: The insulin resistance atherosclerosis study
BV Howard, EJ Mayer-Davis, D Goff, DJ Zaccaro, A Laws, DC Robbins, MF Saad, J Selby, RF Hamman, RM Krauss, SM Haffner
Metabolism 1998
The Dietitian's Role in Developing and Implementing the First Federal Obesity Guidelines
LV Horn, K Donato, S Kumanyika, M Winston, T Prewitt, L Snetselaar
Journal of the American Dietetic Association 1998
Serum Lipid Physiology and the Influence of Glaucoma Medications
WC Stewart, J Osterman
Survey of Ophthalmology 1998
VASCULAR DISEASE AND LIPIDS IN DIABETES
AJ Garber
Medical Clinics of North America 1998
Use of Niacin, Statins, and Resins in Patients With Combined Hyperlipidemia
BG PhD, AZ MD, DP BS, AR MS, VM MD, JW BS, JJ PhD, JD MD
The American Journal of Cardiology 1998
Did grandma give you heart disease? The new battle against coronary artery disease
HR Superko
The American Journal of Cardiology 1998
Cardiovascular risk continuum: implications of insulin resistance and diabetes
WA Hsueh, RE Law
The American Journal of Medicine 1998
The lipoprotein and coronary atherosclerosis study (LCAS): lipid and metabolic factors related to atheroma and clinical events
JA Herd
The American Journal of Medicine 1998
Inverse association of serum cholesterol with plasma insulin in the elderly. Cross-sectional and prospective analyses
O Lindberg, RS Tilvis, TE Strandberg, A Lehtonen, C Ehnholm, J Tuomilehto
Aging clinical and experimental research 1998
Insulin and Coronary Artery Disease: Is Syndrome X the Unifying Hypothesis?
GM Baillie, JT Sherer, CW Weart
The Annals of pharmacotherapy 1998
Hypertriglyceridemia and insulin resistance: CASE REPORT: HYPERTRIGLYCERIDEMIA AND INSULIN RESISTANCE
HÖlzl, Paulweber, Sandhofer, Patsch
Journal of Internal Medicine 1998
Relationship Between Insulin Resistance and Partially Oxidized LDL Particles in Healthy, Nondiabetic Volunteers
M Carantoni, F Abbasi, F Warmerdam, M Klebanov, PW Wang, YD Chen, S Azhar, GM Reaven
Arteriosclerosis, thrombosis, and vascular biology 1998
Influence of ApoE Content on Receptor Binding of Large, Buoyant LDL in Subjects With Different LDL Subclass Phenotypes
CM Barbagallo, GA Levine, PJ Blanche, BY Ishida, RM Krauss
Arteriosclerosis, thrombosis, and vascular biology 1998
Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity
NF Galeano, M Al-Haideri, F Keyserman, SC Rumsey, RJ Deckelbaum
Journal of lipid research 1998
The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal failure
P Lee, D O'Neal, B Murphy, J Best
American Journal of Kidney Diseases 1997
Low-density lipoprotein subclasses: mechanisms of formation and modulation
BA Griffin
Proceedings of the Nutrition Society 1997
High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis
P Lee, D O'Neal, B Murphy, J Best
Australian and New Zealand Journal of Medicine 1997
Pharmacological Treatment and Mechanisms of Insulin Resistance
WA Hsueh, RE Law
Annals of the New York Academy of Sciences 1997
Heritability of factors of the insulin resistance syndrome in women twins
KL Edwards, B Newman, E Mayer, JV Selby, RM Krauss, MA Austin
Genetic Epidemiology 1997
Analytical capillary isotachophoresis of human serum lipoproteins
G Schmitz, C Möllers, V Richter
Electrophoresis 1997
Progress in Population Analyses of the Insulin Resistance Syndrome
SM Haffner
Annals of the New York Academy of Sciences 1997
Family history: A comprehensive genetic risk assessment method for the chronic conditions of adulthood
MT Scheuner, SJ Wang, LJ Raffel, SK Larabell, JI Rotter
American Journal of Medical Genetics 1997
Cardiovascular risk factors in women
CM Williams
Proceedings of the Nutrition Society 1997
Triacylglycerol and coronary heart disease
MA Austin
Proceedings of the Nutrition Society 1997
Characterization of low-density lipoprotein subclasses in children
O Arisaka, S Fujiwara, K Yabuta, H Mokuno, Y Mitugi, N Miyake
Metabolism 1997
Insulin resistance is not a major determinant of low-density lipoprotein particle size
AH Slyper, S Zvereva, G Schechtman, RG Hoffmann, RA Mueller, JA Walker
Metabolism 1997
Decreased glucose tolerance, not decreased insulin sensitivity, is a maturational abnormality in the male offspring of a parent with early coronary artery disease
AH Slyper, S Zvereva, J Pleuss, RG Hoffmann, T Myers, JA Walker
Metabolism 1997
Low-density lipoprotein subfraction profiles in dialysis patients
A BOFINGER, J WESTHUYZEN, D SALTISSI, C MORGAN, H HEALY
Nephrology 1997
Metabolic Syndrome X: A Postmenopausal Woman's Hidden Nemesis
LB Ransdell, H Shaw, D Ostlund
Journal of Women & Aging 1997
The prediabetic problem: Development of non-insulin-dependent diabetes mellitus and related abnormalities
S Haffner
Journal of Diabetes and its Complications 1997
Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease
SM MD, HM MD
The American Journal of Medicine 1997
The effects of exercise on primary and secondary coronary heart disease
B Davies
Coronary Health Care 1997
Epidemiology of hypertension and insulin resistance syndrome:
SM Haffner
Journal of Hypertension 1997
The insulin resistance syndrome and postprandial lipid intolerance in smokers
B Eliasson, N Mero, MR Taskinen, U Smith
Atherosclerosis 1997
Neuropatia vegetativa em pacientes com tolerância diminuída à glicose
KF Rezende, A Melo, J Pousada, ZF Rezende, NL Santos, I Gomes
Arquivos de Neuro-Psiquiatria 1997
Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease
M Halle, D König, A Berg, J Keul, MW Baumstark
Atherosclerosis 1997
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
CJ Packard, J Shepherd
Arteriosclerosis, thrombosis, and vascular biology 1997
Defects of Insulin Action on Fatty Acid and Carbohydrate Metabolism in Familial Combined Hyperlipidemia
TJ Aitman, IF Godsland, B Farren, D Crook, HJ Wong, J Scott
Arteriosclerosis, thrombosis, and vascular biology 1997
LDL Subclass Patterns and Lipoprotein Response to a Low-Fat, High-Carbohydrate Diet in Women
DM Dreon, HA Fernstrom, PT Williams, RM Krauss
Arteriosclerosis, thrombosis, and vascular biology 1997
Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease: An 8-Year Follow-up in the Copenhagen Male Study
J Jeppesen, HO Hein, P Suadicani, F Gyntelberg
Arteriosclerosis, thrombosis, and vascular biology 1997
Genetic Relationship Between Measures of HDL Phenotypes and Insulin Concentrations
DL Rainwater, BD Mitchell, MC Mahaney, SM Haffner
Arteriosclerosis, thrombosis, and vascular biology 1997
Relationship of LDL Size to Insulin Sensitivity in Normoglycemic Men
L Mykkänen, SM Haffner, DL Rainwater, P Karhapää, H Miettinen, M Laakso
Arteriosclerosis, thrombosis, and vascular biology 1997
Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians: The Strong Heart Study
RS Gray, DC Robbins, W Wang, JL Yeh, RR Fabsitz, LD Cowan, TK Welty, ET Lee, RM Krauss, BV Howard
Arteriosclerosis, thrombosis, and vascular biology 1997
Small LDL, Atherogenic Dyslipidemia, and the Metabolic Syndrome
SM Grundy
Circulation 1997
Clinical Research in Diabetes and Obesity
B Draznin, R Rizza
1997
Nonobese Patients With Familial Combined Hyperlipidemia Are Insulin Resistant Compared With Their Nonaffected Relatives
SJ Bredie, CJ Tack, P Smits, AF Stalenhoef
Arteriosclerosis, thrombosis, and vascular biology 1997
Thrombophilia in Patients with Hypertriglyceridemia
Chan, Huang, Shieh, Lin, Tsai
Journal of Thrombosis and Thrombolysis 1997
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
HO Steinberg, H Chaker, R Leaming, A Johnson, G Brechtel, AD Baron
Journal of Clinical Investigation 1996
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients
EJ Sijbrands, RG Westendorp, MJ Hoffer, RR Frants, AE Meinders, JH Souverijn, JA Leuven, AV der Laarse, LM Havekes, AH Smelt
Atherosclerosis 1996
High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy
T Hirano, H Naito, M Kurokawa, T Ebara, S Nagano, M Adachi, G Yoshino
Atherosclerosis 1996
Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations
AL Torres, S Moorjani, MC Vohl, C Gagné, B Lamarche, LD Brun, PJ Lupien, JP Després
Atherosclerosis 1996
Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis
D O'Neal, P Lee, B Murphy, J Best
American Journal of Kidney Diseases 1996
Lipids and atherogenesis in diabetes mellitus
DJ Betteridge
Atherosclerosis 1996
Hypertriglyceridemia and its Metabolic Consequences as a Risk Factor for Atherosclerotic Cardiovascular Disease in Non-Insulin-Dependent Diabetes Mellitus
GF Lewis, G Steiner
Diabetes/Metabolism Reviews 1996
Role of lipids in development of noninsulin-dependent diabetes mellitus: Lessons learned from pima indians
PA Tataranni, LJ Baier, G Paolisso, BV Howard, E Ravussin
Lipids 1996
Multilocus genetic determinants of LDL particle size in coronary artery disease families
JI Rotter, X Bu, RM Cantor, CH Warden, J Brown, RJ Gray, PJ Blanche, RM Krauss, AJ Lusis
The American Journal of Human Genetics 1996
Cardiovascular Risk Factors and the Prediabetic Syndrome
SM Haffner
Annals of Medicine 1996
Metabolic risk factors for cardiovascular disease in a working population: A retrospective cohort study
B Gumbiner, EM Andresen, FT Hearne, TE Michaelson, M Bryson, WM Lednar, R Cass
Journal of Clinical Epidemiology 1996
Selective screening for dyslipidemia in a Canadian population
BA Reeder, L Liu, L Horlick
Journal of Clinical Epidemiology 1996
Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans
V Anber, BA Griffin, M McConnell, CJ Packard, J Shepherd
Atherosclerosis 1996
A case report on the effect of training and low caloric diet in hypertension, obesity and hyperinsulinemia
L Palleschi, F Vetta, E Degennaro, G Devincentis, F Scopinaro, P Cicconetti, V Marigliano
Archives of Gerontology and Geriatrics 1996
New Insights into Lipid Metabolism in Non-insulin-dependent Diabetes Mellitus
MR Taskinen, S Lahdenperä, M Syvänne
Annals of Medicine 1996
Genetic Epidemiology of Dyslipidaemia and Atherosclerosis
MA Austin
Annals of Medicine 1996
Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study
RD Siegel, A Cupples, EJ Schaefer, PW Wilson
Metabolism 1996
7 Metabolic effects of the menopause and oestrogen replacement
JC Stevenson
Baillière's Clinical Obstetrics and Gynaecology 1996
Increase in plasma high-density lipoprotein2b subclass protein concentration after pravastatin treatment in patients with hypercholesterolemia
T Hibino, N Sakuma, A Yoneyama, T Sato, T Fujinami
Current Therapeutic Research 1996
Role of Insulin Resistance Associated With Compensatory Hyperinsulinemia in Ischemic Stroke
K Shinozaki, H Naritomi, T Shimizu, M Suzuki, M Ikebuchi, T Sawada, Y Harano
Stroke; a journal of cerebral circulation 1996
Compositional Differences of LDL Particles in Normal Subjects With LDL Subclass Phenotype A and LDL Subclass Phenotype B
WH Capell, A Zambon, MA Austin, JD Brunzell, JE Hokanson
Arteriosclerosis, thrombosis, and vascular biology 1996
Angiology in Practice
AM Salmasi, A Strano
1996
Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group
M Tilly-Kiesi, P Knudsen, L Groop, MR Taskinen
Journal of lipid research 1996
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance
KC Tan, MB Cooper, KL Ling, BA Griffin, DJ Freeman, CJ Packard, J Shepherd, CN Hales, DJ Betteridge
Atherosclerosis 1995
Influence of Dietary Fatty Acids on the Atherogenic Lipoprotein Phenotype
BA Griffin, A Zampelas
Nutrition Research Reviews 1995
LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes
S Lahdenperä, T Sane, H Vuorinen-Markkola, P Knudsen, MR Taskinen
Atherosclerosis 1995
Factors Influencing the Low Density Lipoprotein Profile in Type 2 Diabetic Patients
RW James, M Marini, J Ruiz, D Pometta
Diabetic Medicine 1995
Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype
P Båvenholm, F Karpe, A Proudler, P Tornvall, D Crook, A Hamsten
Metabolism 1995
Insights Into the Pathogenesis and Prevention of Coronary Artery Disease
JH O'Keefe, CJ Lavie, BD Mccallister
Mayo Clinic Proceedings 1995
Clinical implications of insulin resistance syndromes
MB Davidson
The American Journal of Medicine 1995
Low-density lipoprotein heterogeneity
BA Griffin
Baillière's Clinical Endocrinology and Metabolism 1995
Dense low density lipoproteins and coronary artery disease
RM Krauss
The American Journal of Cardiology 1995
Obesity, lipids, cardiovascular risk, and androgen excess
RA Wild
The American Journal of Medicine 1995
Low density lipoproteins and atherosclerosis—quantity or quality?
FJ Raal, AJ Areias, BI Joffe
Redox Report 1995
Metabolic Abnormalities in Cardiac Ischemia
MF Walsh, LJ Dominguez, JR Sowers
Cardiology Clinics 1995
Insulin Resistance in Microalbuminuric Hypertension: Sites and Mechanisms
S Bianchi, R Bigazzi, AQ Galvan, E Muscelli, G Baldari, N Pecori, D Ciociaro, E Ferrannini, A Natali
Hypertension 1995
Persistence of Low HDL-C Levels After Weight Reduction in Older Men With Small LDL Particles
LI Katzel, PJ Coon, E Rogus, RM Krauss, AP Goldberg
Arteriosclerosis, thrombosis, and vascular biology 1995
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti
1995
LDL Physical and Chemical Properties in Familial Combined Hyperlipidemia
JE Hokanson, RM Krauss, JJ Albers, MA Austin, JD Brunzell
Arteriosclerosis, thrombosis, and vascular biology 1995
Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women
CE Tan, L Forster, MJ Caslake, D Bedford, TD Watson, M McConnell, CJ Packard, J Shepherd
Arteriosclerosis, thrombosis, and vascular biology 1995
Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina
K Shinozaki, M Suzuki, M Ikebuchi, H Takaki, Y Hara, M Tsushima, Y Harano
Circulation 1995
Prospective Study of Small LDLs as a Risk Factor for Non–Insulin Dependent Diabetes Mellitus in Elderly Men and Women
MA Austin, L Mykkänen, J Kuusisto, KL Edwards, C Nelson, SM Haffner, K Pyörälä, M Laakso
Circulation 1995
Effect of Diabetes on Lipoprotein Size
AT Singh, DL Rainwater, SM Haffner, JL VandeBerg, WR Shelledy, PH Moore, TD Dyer
Arteriosclerosis, thrombosis, and vascular biology 1995
Changes of lipolytic enzymes cluster with insulin resistance syndrome
P Knudsen, J Eriksson, S Lahdenper, J Kahri, L Groop,
Diabetologia 1995
Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology
KR Kulkarni, DW Garber, MK Jones, JP Segrest
Journal of lipid research 1995
Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM):
BH Wolffenbuttel, TW van Haeften
Drugs 1995
A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects.
Haffner SM, Mykkänen L, Robbins D, Valdez R, Miettinen H, Howard BV, Stern MP, Bowsher R
Diabetologia 1995
Lewis phenotypes, insulin resistance, and risk of ischaemic heart disease
K Meeran, SR Bloom
British heart journal 1994
Small, dense low-density lipoprotein as a risk factor for coronary heart disease
MA Austin
International Journal of Clinical & Laboratory Research 1994
Diabetic dyslipidemia
DJ Betteridge
The American Journal of Medicine 1994
Syndrome X: Is one enough?
GM Reaven
American Heart Journal 1994
The Visceral Adiposity Syndrome in Japanese-American Men
WY Fujimoto, SL Abbate, SE Kahn, JE Hokansno, JD Brunzell
Obesity research 1994
Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles
LI Katzel, RM Krauss, AP Goldberg
Arteriosclerosis Thrombosis and Vascular Biology 1994
Lipoprotein abnormalities in non-insulin-dependent diabetic patients with impaired extrahepatic insulin sensitivity, hypertension, and microalbuminuria
S Zambon, E Manzato, A Solini, M Sambataro, E Brocco, G Sartore, G Crepaldi, R Nosadini
Arteriosclerosis Thrombosis and Vascular Biology 1994
Multivariate analysis of the insulin resistance syndrome in women
KL Edwards, MA Austin, B Newman, E Mayer, RM Krauss, JV Selby
Arteriosclerosis Thrombosis and Vascular Biology 1994
Effects of exercise training on the chemical composition of plasma LDL
JA Houmard, NJ Bruno, RK Bruner, MR McCammon, RG Israel, HA Barakat
Arteriosclerosis Thrombosis and Vascular Biology 1994
Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects
L Mykkänen, J Kuusisto, SM Haffner, K Pyörälä, M Laakso
Arteriosclerosis Thrombosis and Vascular Biology 1994
Exercise and Diet in the Prevention and Control of the Metabolic Syndrome:
RJ Barnard, SJ Wen
Sports Medicine 1994
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
Reaven GM, Laws A
Diabetologia 1994
Syndrome X: what's old, what's new, what's etiologic?
HN Ginsberg
Journal of Clinical Investigation 1993
Insulin Resistance
A Voll, J Kloster
Acta Medica Scandinavica 1957

← Previous 1 2 3 … 19 20 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 1 policy sources
Posted by 21 X users
Referenced in 1 patents
On 1 videos
Referenced in 1 clinical guideline sources
131 readers on Mendeley
1 readers on CiteULike
See more details